News & Events
New funding to CPR Program will expand service offered to patients suffering with Breast Cancer, Cervical Cancer, Hepatitis C, Multiple Myeloma and Myelodysplastic Syndromes who are in need of financial assistance.
Pharmaceutical Co-payments Now More Affordable for Patients with Cervical Cancer
The Co-Pay Relief program now offers funds to help patients afford treatment associated with the selective absence of fat from various parts of the body.
Co-Pay Relief Program supports patients with Non-Small Cell Lung Cancer who have an identified Molecular Biomarker and are on targeted therapy.
The second oldest co-pay assistance program in America, CPR has provided patients with over $200 million in direct financial assistance to help with copayment costs since inception.
The launch of the CPR Silo for Hepatitis C patients will provide financial assistance to those who need help affording their pharmaceutical medications and treatments.
CPR helps make pharmaceutical co-payments now more affordable for patients with metastatic gastric cancer
Co-Pay Relief’s parent organization is recognized with near-perfect rating awarded for “Financial Performance, Accountability and Transparency”
Patient Advocate Foundation Announces $3 Million Donation to its Co-Pay Relief (CPR) ProgramAdditional Funding to CPR Program Will Serve Chemotherapy Induced Neutropenia Patients in Need of Financial Assistance
HAMPTON, VA (February 4, 2013) - Patient Advocate Foundation (PAF) announced today its formation of a new Castrate Resistant Prostate Cancer Silo within its Co-Pay Relief (CPR) program